TEACHERS ADVISORS, LLC - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 114 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.

Quarter-by-quarter ownership
TEACHERS ADVISORS, LLC ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q1 2019$2,636,000
-17.5%
451,424
+32.4%
0.00%
-25.0%
Q4 2018$3,195,000
-72.2%
340,960
-49.5%
0.00%
-42.9%
Q3 2018$11,494,000
+103.4%
674,956
+102.9%
0.01%0.0%
Q2 2018$5,652,000
-3.1%
332,678
-23.4%
0.01%
-12.5%
Q1 2018$5,830,000
+39.7%
434,437
-0.0%
0.01%
+60.0%
Q4 2017$4,172,000
-11.9%
434,602
+0.7%
0.01%
-16.7%
Q3 2017$4,738,000
+21.4%
431,502
+0.0%
0.01%
+20.0%
Q2 2017$3,904,000
-27.7%
431,350
+2.6%
0.01%
-37.5%
Q1 2017$5,400,000
+1288.2%
420,563
+915.0%
0.01%
+700.0%
Q4 2016$389,000
+11.1%
41,436
+15.0%
0.00%0.0%
Q3 2016$350,000
+44.6%
36,0170.0%0.00%
Q2 2016$242,000
-25.8%
36,017
-1.4%
0.00%
-100.0%
Q1 2016$326,000
-32.6%
36,5320.0%0.00%0.0%
Q4 2015$484,000
+36.3%
36,532
+8.3%
0.00%0.0%
Q3 2015$355,000
-84.9%
33,726
-60.9%
0.00%
-75.0%
Q2 2015$2,349,000
+4.1%
86,336
+17.1%
0.00%0.0%
Q1 2015$2,256,000
-14.1%
73,717
+5.1%
0.00%
-20.0%
Q4 2014$2,625,000
+7.0%
70,134
-0.1%
0.01%0.0%
Q3 2014$2,454,000
-18.3%
70,224
+8.8%
0.01%
-16.7%
Q2 2014$3,004,000
+768.2%
64,524
+475.3%
0.01%
+500.0%
Q1 2014$346,000
+36.8%
11,216
+1.6%
0.00%0.0%
Q4 2013$253,00011,0360.00%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Delphi Management Partners VIII, L.L.C. 2,263,006$35,031,00023.03%
Palo Alto Investors LP 5,267,652$81,543,0004.28%
Fairmount Funds Management LLC 702,351$10,872,0003.89%
Birchview Capital, LP 188,000$2,910,0001.68%
Mesirow Financial Investment Management, Inc. 22,303$345,250,0001.09%
EMERALD ADVISERS, LLC 1,822,781$28,217,0000.94%
EMERALD MUTUAL FUND ADVISERS TRUST 1,661,236$25,716,0000.90%
RICE HALL JAMES & ASSOCIATES, LLC 1,552,504$24,033,0000.85%
Altium Capital Management LP 133,951$2,074,0000.77%
Hood River Capital Management LLC 931,754$14,424,0000.48%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders